Review
Published on 07 Oct 2022
The treatment of depression — searching for new ideas
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.988648
- 18,167 views
- 37 citations
Type at least 3 characters
2,453 articles
Editorial
Published on 07 Oct 2022
Editorial: Novel therapeutic target and drug discovery for neurological diseases
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1042266
- 3,084 views
- 1 citation
Review
Published on 07 Oct 2022
Comorbid epilepsy and depression—pharmacokinetic and pharmacodynamic drug interactions
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.988716
- 6,767 views
- 7 citations
Original Research
Published on 07 Oct 2022
LncRNA KCNQ1OT1 predicts further cerebral events in patients with transient ischemic attack
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.961190
- 2,144 views
- 2 citations
Original Research
Published on 06 Oct 2022
Neutrophilic noncoding RNAs predict outcomes of acute ischemic stroke patients treated with recombinant tissue plasminogen activator
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1003806
- 1,631 views
- 3 citations
Original Research
Published on 06 Oct 2022
Antioxidant-based neuroprotective effect of dimethylsulfoxide against induced traumatic brain injury in a rats model
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.998179
- 6,809 views
- 13 citations
Mini Review
Published on 06 Oct 2022
Epilepsy treatment in neuro-oncology: A rationale for drug choice in common clinical scenarios
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.991244
- 12,829 views
- 12 citations
Review
Published on 06 Oct 2022
Multifunctional role of natural products for the treatment of Parkinson’s disease: At a glance
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.976385
- 17,839 views
- 33 citations
Original Research
Published on 06 Oct 2022
LPS activates neuroinflammatory pathways to induce depression in Parkinson’s disease-like condition
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.961817
- 7,462 views
- 22 citations
Original Research
Published on 05 Oct 2022
Protective effect of zinc oxide nanoparticles on spinal cord injury
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.990586
- 3,334 views
- 9 citations
Original Research
Published on 05 Oct 2022
Identification of minimum essential therapeutic mixtures from cannabis plant extracts by screening in cell and animal models of Parkinson’s disease
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.907579
- 8,563 views
- 5 citations
Original Research
Published on 05 Oct 2022
Investigation of Natural Compounds for Therapeutic Potential in Streptozotocin-induced Diabetic Neuroinflammation and Neuropathic Pain
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1019033
- 4,059 views
- 12 citations
Original Research
Published on 04 Oct 2022
NLRP3 neuroinflammatory factors may be involved in atopic dermatitis mental disorders: an animal study
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.966279
- 3,131 views
- 7 citations
Review
Published on 03 Oct 2022
Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.927703
- 16,035 views
- 20 citations
Editorial
Published on 03 Oct 2022
Editorial: Natural products and brain energy metabolism: Astrocytes in neurodegenerative diseases
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1039904
- 2,429 views
- 1 citation
Original Research
Published on 03 Oct 2022
ApoE isoform-dependent effects of xanthohumol on high fat diet-induced cognitive impairments and hippocampal metabolic pathways
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.954980
- 3,465 views
- 7 citations